CVE:QPT Quest PharmaTech (QPT) Stock Price, News & Analysis → Warning: this could blow your mind (From DTI) (Ad) Free QPT Stock Alerts C$0.02 0.00 (0.00%) (As of 03/18/2024) Add Compare Share Share Today's RangeC$0.03▼C$0.0350-Day RangeC$0.02▼C$0.0452-Week RangeC$0.02▼C$0.11Volume12,000 shsAverage Volume64,635 shsMarket CapitalizationC$4.23 millionP/E RatioN/ADividend Yield6.15%Price TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades Get Quest PharmaTech alerts: Email Address Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here About Quest PharmaTech Stock (CVE:QPT)Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.Read More QPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart QPT Stock News HeadlinesFebruary 20, 2024 | theglobeandmail.comQuest PharmaTech: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (QPT)February 20, 2024 | theglobeandmail.comPsyBio Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (PSYB)March 28, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.February 19, 2024 | theglobeandmail.comMarvel Biosciences: Top 10 Undervalued Biotechnology Industry Stocks (MRVL)February 6, 2024 | finance.yahoo.comQuest PharmaTech Inc. (QPT.V)January 30, 2024 | ca.finance.yahoo.comQuest Receives Cash Dividend Payment from OncoQuestJanuary 21, 2024 | theglobeandmail.comQuest PharmaTech: Top 10 Undervalued Biotechnology Industry Stocks (QPT)January 2, 2024 | cnet.comBest Meta Quest 2 Accessories for 2024March 28, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. November 6, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc up on Thursday (QPT)October 14, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Thursday (QPT)September 29, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Tuesday (QPT)September 16, 2023 | time.comMeta Quest Promo CodesAugust 24, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc up on Tuesday (QPT)August 17, 2023 | ca.finance.yahoo.comQPT.V - Quest PharmaTech Inc.August 5, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Monday (QPT)July 10, 2023 | finance.yahoo.comQuest PharmaTech Provides Product Development UpdateJune 7, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - QPTJune 6, 2023 | finance.yahoo.comQuest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.June 6, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - QPTMay 13, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Thursday (QPT)May 4, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Tuesday (QPT)April 27, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Wednesday (QPT)April 22, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Friday (QPT)April 19, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Monday (QPT)January 26, 2023 | reuters.comQPT.V - | Stock Price & Latest News | ReutersOctober 17, 2022 | finance.yahoo.comCNN's Richard Quest returns to Singapore on Quest's World of WonderSee More Headlines Receive QPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Next Earnings (Estimated)5/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:QPT CUSIPN/A CIKN/A Webwww.questpharmatech.com Phone+1-780-4481400FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-22,260,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-28.86% Return on Assets-0.94% Debt Debt-to-Equity Ratio1.51 Current Ratio0.26 Quick Ratio0.52 Sales & Book Value Annual SalesC$38,871.00 Price / Sales108.78 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueC$0.39 per share Price / Book0.06Miscellaneous Outstanding Shares169,130,000Free FloatN/AMarket CapC$4.23 million OptionableNot Optionable Beta0.29 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Ragupathy Madiyalakan Ph.D.CEO & DirectorMr. Pierre Vermette C.A.CPA, Chief Financial OfficerMr. Roger AndrewsHead of Investor Relations & Corporate CommunicationsMr. Douglas C. Bachman (Age 70)Vice President of Corporate Development Comp: $37.94kMr. Thomas WooVice President of Product DevelopmentKey CompetitorsInnovotechCVE:IOTRevive TherapeuticsCVE:RVVHemostemixCVE:HEMPacgen Life Science Co. (PBS.V)CVE:PBSMedifocus Inc. (MFS.V)CVE:MFSView All CompetitorsInsidersRagupathy MadiyalakanBought 15,290 shares on 9/15/2023Total: C$1,070.30 ($0.07/share)Ragupathy MadiyalakanBought 30,000 shares on 8/29/2023Total: C$2,100.00 ($0.07/share)Ragupathy MadiyalakanBought 20,000 shares on 8/25/2023Total: C$1,400.00 ($0.07/share)View All Insider Transactions QPT Stock Analysis - Frequently Asked Questions How have QPT shares performed in 2024? Quest PharmaTech's stock was trading at C$0.06 at the beginning of the year. Since then, QPT shares have decreased by 54.5% and is now trading at C$0.03. View the best growth stocks for 2024 here. When is Quest PharmaTech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024. View our QPT earnings forecast. What other stocks do shareholders of Quest PharmaTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Quest PharmaTech investors own include Indiva (NDVA), CME Group (CME) and How do I buy shares of Quest PharmaTech? Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:QPT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.